fr   en
Fundraisings
Select a company :
Select an investor :
Choose date:
[<<]      «      6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16      »      [23]
Date Company Amount Investors Planned use / Other
2009-06-15 Ipsogen (France) €2.5 million   See details
2009-06-15 Active Biotech (Sweden) SEK 256 million (€23.6 million)   See details
2009-06-11 InnaVirVax (France) € 1,1 million CapDecisif Management (France)
G1J-Ile de France (France)
See details
2009-06-05 Proximagen Neuroscience (UK) £50 million (before expenses, £49 million net)   See details
2009-06-01 ImmunID (France) €2.4 million Sofimac Partners (France)
Vizille Capital Innovation (France)
CEA Investissement (France)
See details
2009-05-29 Apeptico (Austria) € 1.2 million Austrian Research Promotion Agency (Austria) See details
2009-05-29 Apeptico (Austria) € 1 million BioScience Ventures Group (Germany)
Dr. Jürg Geigy (Swiss business angel)
See details
2009-05-26 Cavadis (The Netherlands) undisclosed Thuja Capital (The Netherlands)
ErasmusMC Biomedical Fund (The Netherlands)
UMC Utrecht Holding BV (The Netherlands)
Universiteit Utrecht Holding BV (The Netherlands)
See details
2009-05-26 Cavadis (The Netherlands) undisclosed Thuja Capital (The Netherlands)
ErasmusMC Biomedical Fund (The Netherlands)
UMC Utrecht Holding BV (The Netherlands)
Universiteit Utrecht Holding (The Netherlands)
See details
2009-05-18 ReNeuron (UK) £ 3 million (€ 3.4 million)   See details
2009-05-12 NovImmune (Switzerland) CHF 62.5 million (€41.5 million) BZ Bank Aktiengesellschaft (Switzerland) See details
2009-04-28 TcLand Expression (France) €1.8 million OSEO (France) See details
2009-04-27 Protaffin (Germany) €14.1 million ($18.4 million) Atlas Venture (USA)
SR One Limited (the venture capital arm of GSK)
Aescap Venture (The Netherlands)
Entrepreneurs Fund (The Netherlands)
Z-Cube (Italy)
See details
2009-04-15 Pharming (The Netherlands) Up to €20 million Yorville Advisors Global Master SPV (YA Global - USA) See details
2009-04-07 KeyNeurotek Pharmaceuticals (Germany) € 8.2 million DVC Deutsche Venture (Germany)
IBG Beteiligungsgesellschaft (Germany)
KfW (Germany)
See details
[<<]      «      6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16      »      [23]